Below is an extract from the Q3 report. In summary it says that subsequent to the end of quarter, post 30 Sep 16, the hold ups were resolved and that thanks to the PO the company has been able to fund parallel paths for development of the optical engine. I wondered what parallel paths meant initially but can now see that this  is a belt and braces approach that takes some of the risk out of the final actions towards commercialisation. It looks to me that sele tive invstment includes new equipment that  gives the capacity to produce the epitaxial needed for development work in house (greater control over the most time sensetive aspects of develoment).   Effectively the PO bought an in house path independent of 3rd party support for design and validation.  To achieve this through a PO has been expensive and shocking for us longs but may well prove to be the key to our hopes for PTK financial performance. 

“In terms of progress on the POET technology, we continue to maintain a strong focus on the development and refinement of the integrated opto-electronics engine, which includes the integrated detector. As a direct result of the capital raise, we are now able to pursue parallel development paths for our VCSEL design and validation and have taken meaningful steps to accelerate our cycles of learning. Furthermore, we are making selective investments in capital equipment as well as other key capabilities to give us greater control over some of the most time-sensitive aspects the technology development process. The previous delays we encountered largely related to epitaxial wafer supply and more recently export license controls were both resolved subsequent to quarter-end, which has enabled us to resume progress toward the production of integrated device prototypes. Although this pre-prototype stage of product development has taken longer than we originally anticipated due to various constraints, we believe we are on the right path to achieve commercialization in 2018.

 My hope is that 2018 set as a date for commercialisation is an under promise and over performance type of statement, but taken at face value  it really should stop the 'I want it now' calls we hear from some thatI accept is caused by frustrations and investment fatigue but do we really need what amounts to the 'are we there yet' pleas we get from our kids on journies .  We just need to wait a while longer, we are near and on the cusp, but lets be absolutelycertain that it is 2018 that is set as the stated target date for commercialisation of POET products. 

sula.